Normal view MARC view

Valuation in life sciences: a practical guide

Author: Bogdan, Boris ; Villiger, RalphPublisher: Springer, 2007.Language: EnglishDescription: 249 p. : Graphs/Ill. ; 24 cm.ISBN: 3540455655Type of document: BookBibliography/Index: Includes bibliographical references and index
Tags: No tags from this library for this title. Log in to add tags.
Item type Current location Collection Call number Status Date due Barcode Item holds
Book Asia Campus
Main Collection
Print HG4028 .V3 B64 2007
(Browse shelf)
900178044
Available 900178044
Book Europe Campus
Main Collection
Print HG4028 .V3 B64 2007
(Browse shelf)
001127335
Available 001127335
Total holds: 0

Includes bibliographical references and index

Digitized

Valuation in Life Sciences A Practical Guide Table of Contents Foreword..................................................................................................... V Abbreviations............................................................................................. XI Introduction................................................................................................ 1 The Life Sciences Industry..................................................................... 2 Academia.............................................................................................2 Biotech................................................................................................ 2 Pharma.................................................................................................3 Valuation................................................................................................. 4 The Role of Valuation......................................................................... 4 Current Problems in Valuation............................................................6 Fundamentals in Life Sciences.................................................................. 9 Drug Development.................................................................................. 9 Drug Discovery................................................................................... 9 Clinical Trials...................................................................................... 10 Value Drivers...................................................................................... 12 Medical Device Development and Approval..........................................18 Development and Approval in Europe................................................18 Development and Approval in the US................................................ 18 Basics of Valuation..................................................................................... 21 Introduction............................................................................................. 21 Fundamentals.......................................................................................... 21 Cash Flows.......................................................................................... 21 Discounting......................................................................................... 23 Valuation Methods.................................................................................. 32 Discounted Cash Flows Valuation...................................................... 32 Real Options........................................................................................ 34 Difference Between Real Options and Financial Options.................. 57 Valuation in Life Sciences..........................................................................65 Discounting............................................................................................. 65 Volatility..................................................................................................69 Peak Sales............................................................................................... 71 Project Valuation.................................................................................... 73 Project Valuation with DCF.............................................................. 75 Project Valuation with Real Options.................................................83 Simulations of Projects..................................................................... 96 License Contract Valuation.................................................................. 105 Structure of License Contracts ....................................................... 105 Value Sharing.................................................................................. 111 Valuation of License Contracts with Two Parties: DCF................ 112 Valuation of License Contracts with Two Parties: Real Options .. 120 Simulation of License Contracts..................................................... 128 Early-Stage Licensing with Possible Sublicensing.............................. 129 Theory DCF.....................................................................................133 Theory Real Options....................................................................... 138 Negotiating License Deals....................................................................154 Valuing Projects with Multiple Indications..........................................160 Valuing Projects with Multiple Markets.............................................. 171 Technology Valuation and Feed Rate.................................................. 172 IP Valuation.......................................................................................... 173 Pipeline Valuation................................................................................ 181 Portfolio Management.......................................................................... 183 Introduction..................................................................................... 183 Qualitative Approaches................................................................... 185 Quantitative Approaches................................................................. 185 Company and Stock Valuation............................................................. 188 Introduction to Company Valuation................................................188 Theory............................................................................................. 190 Interpretation of Valuation Results................................................. 202 Simulation on Company Level........................................................ 204 Case Company Valuation................................................................ 204 Stock Valuation............................................................................... 206 Exercises................................................................................................... 215 Introduction.......................................................................................... 215 Exercises............................................................................................... 215 Solutions.............................................................................................. 221 References.................................................................................................241 Index.......................................................................................................... 243

There are no comments for this item.

Log in to your account to post a comment.
Koha 18.11 - INSEAD Catalogue
Home | Contact Us | What's Koha?